| |
| |
|
| Insider
Information: |
Ho Carole |
| Relationship: |
Chief Medical Officer |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
118,810 |
|
|
Indirect Shares
|
208,219 |
|
|
| Direct
Value |
$3,602,319 |
|
|
|
Indirect Value
|
$6,313,200 |
|
|
| Total
Shares |
327,029 |
|
|
| Total
Value |
$9,915,519 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
7
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-7.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -332.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Denali Therapeutics Inc. |
DNLI |
Chief Medical Officer |
2024-08-21 |
118,810 |
2024-08-21 |
208,219 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2018-08-29 |
4 |
AS |
$18.04 |
$315,700 |
I/I |
(17,500) |
218,390 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2018-09-04 |
4 |
AS |
$19.05 |
$333,375 |
I/I |
(17,500) |
200,890 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2024-01-05 |
4 |
S |
$19.43 |
$193,756 |
I/I |
(9,972) |
198,777 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2020-10-09 |
4 |
OE |
$5.28 |
$158,400 |
I/I |
30,000 |
196,617 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2018-11-15 |
4/A |
OE |
$5.28 |
$64,601 |
I/I |
12,235 |
195,625 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2018-12-03 |
4/A |
OE |
$5.28 |
$92,400 |
I/I |
17,500 |
195,625 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2020-10-08 |
4 |
OE |
$5.28 |
$120,944 |
I/I |
22,906 |
189,523 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-08-10 |
4 |
S |
$24.15 |
$68,997 |
I/I |
(2,857) |
185,577 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-08-21 |
4 |
S |
$22.60 |
$56,003 |
I/I |
(2,478) |
185,331 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-02-13 |
4 |
AS |
$30.10 |
$76,695 |
I/I |
(2,548) |
184,285 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-04 |
4/A |
OE |
$5.28 |
$31,416 |
I/I |
5,950 |
184,075 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-02 |
4/A |
OE |
$5.28 |
$30,492 |
I/I |
5,775 |
183,900 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-03 |
4/A |
OE |
$5.28 |
$30,492 |
I/I |
5,775 |
183,900 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2018-10-01 |
4 |
AS |
$21.72 |
$380,100 |
I/I |
(17,500) |
183,390 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-02-15 |
4 |
AS |
$29.40 |
$43,394 |
I/I |
(1,476) |
182,809 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-08-14 |
4 |
AS |
$23.79 |
$65,851 |
I/I |
(2,768) |
182,809 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-08-23 |
4 |
AS |
$23.22 |
$58,561 |
I/I |
(2,522) |
182,809 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-01-05 |
4 |
AS |
$28.44 |
$74,968 |
I/I |
(2,636) |
180,364 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-02-08 |
4 |
S |
$30.88 |
$46,968 |
I/I |
(1,521) |
180,183 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-02-10 |
4 |
AS |
$29.80 |
$24,376 |
I/I |
(818) |
179,365 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-01-06 |
4 |
AS |
$28.67 |
$41,600 |
I/I |
(1,451) |
178,913 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2018-11-15 |
4/A |
AS |
$18.07 |
$316,157 |
I/I |
(17,500) |
178,125 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2018-12-03 |
4/A |
AS |
$18.43 |
$322,834 |
I/I |
(17,500) |
178,125 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-02 |
4/A |
AS |
$19.43 |
$112,937 |
I/I |
(5,775) |
178,125 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-03 |
4/A |
AS |
$18.90 |
$109,148 |
I/I |
(5,775) |
178,125 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
